EndoLipiD Therapeutics

EDL6D a new NASH therapy

OWNER

Albert Palomer (See Profile)


Sector

Therapeutics

Stage

Prototyping, preclinical

Country

Spain

PEPTIDES THAT MIMIC THE ACTION OF SHBG: A PATENTED AND SCIENTIFICALLY PROVEN INNOVATION IN NASH.

READY-TO-DEVELOP PEPTIDE WITH POC-VALIDATED EFFICACY: EDL6D FOR NASH.

NASH, A GROWING AND UNTREATED DISEASE AND AN OPPORTUNITY FOR AN EFFECTIVE PEPTIDE WITH A NOVEL AND DIFFERENTIATED MOA.

Status

Approved

IP Type

PCT

Time

14 years

Countries

Austria
Belgium
Denmark
Finland
France
Germany
Italy
Netherlands
Spain
USA
United Kingdom

Coverage

Sex hormone-binding globulin and/or any fragment thereof for use as a medicament, in particular for use in the treatment of obesity and hepatic steatosis. The invention also relates to the cosmetic use of the sex hormone-binding globulin and/or any fragment thereof for improving the bodily appearance of a mammal with subcutaneous fat herniated or accumulated within the fibrous connective tissue under the skin, in particular the cosmetic use is for cellulite.

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: 7th of April 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar